Final answer:
Wegovy is dosed higher than Ozempic for weight loss. Both contain the active ingredient semaglutide, but Wegovy's dosing is intended for weight loss and can be increased up to a 2.4 mg once-weekly dose, while Ozempic's typical target dose for diabetes is 1 mg weekly.
Step-by-step explanation:
The medication dosed higher for weight loss is Wegovy. Both Wegovy and Ozempic contain semaglutide, a medication approved for managing type 2 diabetes and for weight loss in some cases. However, Wegovy is specifically approved and dosed for weight loss. Its doses are higher compared to Ozempic, which is primarily used at lower doses for blood sugar control in type 2 diabetes. Wegovy's dosing starts at 0.25 mg once weekly and it's intended to be increased gradually over time up to a 2.4 mg once-weekly dose for weight loss. In contrast, Ozempic is typically started at 0.25 mg once weekly and is eventually increased to a target dose of 1 mg per week for diabetes management.